Colleen M O'Connor

Title: Colleen M O'Connor: Innovator in Canine Immunotherapy

Introduction

Colleen M O'Connor is a prominent inventor based in Houston, TX (US). She has made significant contributions to the field of veterinary medicine, particularly in the treatment of canine diseases. With a total of 2 patents, her work focuses on innovative therapies that enhance the immune response in dogs.

Latest Patents

One of her latest patents is titled "Treatment of a canine CD20 positive disease or condition using a canine CD20-specific chimeric antigen receptor." This invention relates to compositions and methods for treating canine CD20 positive diseases using modified canine T cells and pharmaceutical compositions for adoptive cell therapy. Another notable patent is "Compositions and methods for treating immunological dysfunction," which directs methods of lymphotherapy aimed at treating cancer, infections, and autoimmune diseases in canines.

Career Highlights

Colleen has worked with various institutions, including the University of Pennsylvania, where she has contributed to advancing veterinary immunotherapy. Her innovative approaches have garnered attention in the scientific community, leading to advancements in the treatment of canine diseases.

Collaborations

Throughout her career, Colleen has collaborated with notable professionals in her field, including Nicola Mason and Daniel J Powell. These partnerships have further enhanced her research and development efforts in veterinary medicine.

Conclusion

Colleen M O'Connor's work exemplifies the intersection of innovation and veterinary science. Her patents and research are paving the way for new treatments that improve the health and well-being of canines.